mannitol IV
Selected indexed studies
- Astragaloside IV Inhibited Podocyte Pyroptosis in Diabetic Kidney Disease by Regulating SIRT6/HIF-1α Axis. (DNA Cell Biol, 2023) [PMID:37751175]
- Renal impairment and prognosis in mannitol-treated intracerebral hemorrhage: a retrospective clinical analysis. (J Clin Neurosci, 2025) [PMID:41092697]
- A Semi-Physiological Three-Compartment Model Describes Brain Uptake Clearance and Efflux of Sucrose and Mannitol after IV Injection in Awake Mice. (Pharm Res, 2022) [PMID:35146590]
_Worker-drafted node — pending editorial review._
Connections
mannitol IV is a side effect of
Sources
- Astragaloside IV Inhibited Podocyte Pyroptosis in Diabetic Kidney Disease by Regulating SIRT6/HIF-1α Axis. (2023) pubmed
- Renal impairment and prognosis in mannitol-treated intracerebral hemorrhage: a retrospective clinical analysis. (2025) pubmed
- A Semi-Physiological Three-Compartment Model Describes Brain Uptake Clearance and Efflux of Sucrose and Mannitol after IV Injection in Awake Mice. (2022) pubmed
- Impact of mannitol on mortality in patients with non-traumatic intracerebral haemorrhage and acute kidney injury: a retrospective study. (2025) pubmed
- Management of Intracranial Pressure. (2015) pubmed
- Contrast-Induced Encephalopathy: A Clinical Conundrum. (2022) pubmed
- Mannitol Augments the Effects of Systemical Stem Cell Transplantation without Increasing Cell Migration in a Stroke Animal Model. (2020) pubmed
- Hyperosmolar therapy for intracranial hypertension. (2012) pubmed
- Ciguatera fish poisoning: treatment, prevention and management. (2008) pubmed
- Mannitol pharmacokinetics and serum osmolality in dogs and humans. (1986) pubmed